Adiponectin Inhibits ROS/NLRP3 Inflammatory Pathway Through FOXO3A to Ameliorate Oral Submucosal Fibrosis

Overview

Journal Odontology

Specialty Dentistry

Date 2024 Jan 13

PMID 38217790

Authors

Yuanyuan Zeng

Mengshen Luo

Zhilong Yao

Xiaoping Xiao

Affiliations

Soon will be listed here.

Abstract

Oral submucous fibrosis (OSF) is an oral condition characterized by chronic progression, which may lead to the development of malignancy. Currently, available treatments for OSF only provide temporary relief of symptoms, and there is a limited availability of effective interventions that can effectively cure this condition. In this study, we aimed to investigate whether adiponectin (APN) could ameliorate OSF and the mechanisms involved in it. First, human oral mucosal fibroblasts (HOMFs) were cultured, an OSF model was established using arecoline, and APN and Imiquimod treatment were administered. Then we overexpressed NLRP3 and knocked down FOXO3A. FOXO3A, fibrosis-related factors (ɑ-SMA, COL1A, CTGF), TGF-β1/Smad3 signaling-related factors (TGF-β1, p-Smad3, Smad3), NLRP3 inflammasome-related factors (NLRP3, Caspase-1, IL-1β), and ROS levels were evaluated. Finally, we explored the effect of APN on OSF in mice by in vivo experiments. We found that arecoline significantly increased ɑ-SMA, COL1A, CTGF, and TGF-β1 expressions and promoted Smad3 phosphorylation, while APN significantly inhibited the elevation of these fibrosis-related factors. ROS production was significantly elevated in HOMFs after arecoline treatment, while APN treatment inhibited ROS production. However, the addition of Imiquimod and overexpression of NLRP3 exhibited a trend of elevated ROS, resisting the inhibitory effect of APN. Furthermore, adding Imiquimod and overexpression of NLRP3 elevated ɑ-SMA, COL1A and CTGF and activated TGF-β1/Smad3 signaling pathway. Additionally, knockdown of FOXO3A enhanced APN-inhibited ɑ-SMA and COL1A. In vivo experiments further confirmed that APN ameliorated OSF in mice by inhibiting ROS/NLRP3 inflammatory pathway. In conclusion, APN ameliorated arecoline-induced OSF by promoting FOXO3A expression and downregulating the ROS/NLRP3 pathway.

References

Qin A, Wu C, Ho M, Tsai C, Chen P . Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. Int J Mol Sci. 2024; 25(1). PMC: 10778875. DOI: 10.3390/ijms25010433. View

Yang T, Chen H, Hu C, Chen L, Shih F, Tantoh D . Interaction of Osteoarthritis and BMI on Promoter Methylation in Taiwanese Adults. Int J Mol Sci. 2019; 21(1). PMC: 6981657. DOI: 10.3390/ijms21010123. View

Li Y, Fu J, Shen Q, Yang D . High-Molecular-Weight Glutenin Subunits: Genetics, Structures, and Relation to End Use Qualities. Int J Mol Sci. 2020; 22(1). PMC: 7795185. DOI: 10.3390/ijms22010184. View

Peng Q, Li H, Chen J, Wang Y, Tang Z . Oral submucous fibrosis in Asian countries. J Oral Pathol Med. 2019; 49(4):294-304. DOI: 10.1111/jop.12924. View

Tilakaratne W, Ekanayaka R, Warnakulasuriya S . Oral submucous fibrosis: a historical perspective and a review on etiology and pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122(2):178-91. DOI: 10.1016/j.oooo.2016.04.003. View

Lye L, Chou R, Wu T, Chuang W, Tsai S, Lin H . Administration of Bevacizumab and the Risk of Chronic Kidney Disease Development in Taiwan Residents: A Population-Based Retrospective Cohort Study. Int J Mol Sci. 2024; 25(1). PMC: 10778964. DOI: 10.3390/ijms25010340. View

Liu B, Shen M, Xiong J, Yuan Y, Wu X, Gao X . Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015; 120(3):337-45. DOI: 10.1016/j.oooo.2015.04.013. View

Rao N, Villa A, More C, Jayasinghe R, Kerr A, Johnson N . Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. J Otolaryngol Head Neck Surg. 2020; 49(1):3. PMC: 6951010. DOI: 10.1186/s40463-020-0399-7. View

10.

Fang H, Judd R . Adiponectin Regulation and Function. Compr Physiol. 2018; 8(3):1031-1063. DOI: 10.1002/cphy.c170046. View

11.

Qi G, Jia L, Li Y, Li H, Du J . Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy. Endocrinology. 2014; 155(6):2254-65. DOI: 10.1210/en.2013-2011. View

12.

Wang X, Yang J, Wu L, Tong C, Zhu Y, Cai W . Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway. Bioengineered. 2022; 13(4):10098-10110. PMC: 9162013. DOI: 10.1080/21655979.2022.2063652. View

13.

Xie M, Xiong Z, Yin S, Xiong J, Li X, Jin L . Adiponectin Alleviates Intestinal Fibrosis by Enhancing AMP-Activated Protein Kinase Phosphorylation. Dig Dis Sci. 2021; 67(6):2232-2243. DOI: 10.1007/s10620-021-07015-0. View

14.

Paik S, Kim J, Silwal P, Sasakawa C, Jo E . An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021; 18(5):1141-1160. PMC: 8093260. DOI: 10.1038/s41423-021-00670-3. View

15.

Huang Y, Xu W, Zhou R . NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021; 18(9):2114-2127. PMC: 8429580. DOI: 10.1038/s41423-021-00740-6. View

16.

Artlett C . The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. Biomolecules. 2022; 12(5). PMC: 9138796. DOI: 10.3390/biom12050634. View

17.

Coll R, Holley C, Schroder K . Mitochondrial DNA synthesis fuels NLRP3 activation. Cell Res. 2018; 28(11):1046-1047. PMC: 6218443. DOI: 10.1038/s41422-018-0093-8. View

18.

Luo T, Zhou X, Qin M, Lin Y, Lin J, Chen G . Corilagin Restrains NLRP3 Inflammasome Activation and Pyroptosis through the ROS/TXNIP/NLRP3 Pathway to Prevent Inflammation. Oxid Med Cell Longev. 2022; 2022:1652244. PMC: 9592212. DOI: 10.1155/2022/1652244. View

19.

Tschopp J, Schroder K . NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?. Nat Rev Immunol. 2010; 10(3):210-5. DOI: 10.1038/nri2725. View

20.

Lee S, Chen Y, Tsai C, Huang F, Chang Y . Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation. Clin Oral Investig. 2015; 20(5):1029-34. DOI: 10.1007/s00784-015-1579-0. View

21.

Tan W, Wang K, Lv D, Li P . Foxo3a inhibits cardiomyocyte hypertrophy through transactivating catalase. J Biol Chem. 2008; 283(44):29730-9. PMC: 2662055. DOI: 10.1074/jbc.M805514200. View